24/7 Patient Assistance: 760-405-8205

Bradley C. Ekstrand, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Bradley Ekstrand graduated the medical school from the Yale University School of Medicine and completed his residency program at the Mount Sinai School of Medicine. A fellowship at the Stanford University followed soon after that. Dr. Ekstrand is specialized in oncology and board certified in internal medicine and medical oncology. He has been in practice for more than 11 years and is affiliated with the Sequoia Hospital. During his career, he has also published four writings of medical interest in collaboration with other doctors.

  • Education & Training


    Yale University

    Medical School


    Mount Sinai School of Medicine



    Stanford University


  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Mills-Peninsula Health Services

    Languages: English/Spanish

    (650) 696-5400

    1501 Trousdale Dr

    Burlingame, California 94010

    Read More

    Sequoia Hospital

    Languages: English/Spanish

    (650) 369-5811

    170 Alameda de las Pulgas

    Redwood City, California 94062

    Read More
  • Publications & Memberships

    Dr. Bradley C. Ekstrand has contributed to 3 publications.

    Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.

    Ekstrand, B.C., Lucas, J.B., Horwitz, S.M., Fan, Z., Breslin, S., Hoppe, R.T., Natkunam, Y., Bartlett, N.L., Horning, S.J.; Blood. 2003 Jun 1.

    See more >>

    Lymphocyte predominant Hodgkin's disease.

    Ekstrand, B.C., Horning, S.J.; Curr Oncol Rep. 2002 Sep.

    See more >>

    Lymphocyte predominant Hodgkin's disease: more patience than patients.

    Ekstrand, B.C., Horning, S.J.; Cancer J. 2002-09-01.

    See more >>


    American Society of Clinical Oncology